$CLDX
Celldex Therapeutics, Inc
XNAS•Health Care•In Vitro & in Vivo Diagnostic Substances
Why is CLDX up today? It is at $40.38 (+1.10%), and our scanner flagged it 48 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment CLDX spikes, and full due diligence on CLDX — key stats, earnings, dilution and insider activity. Free.
Get free $CLDX alerts the moment volume spikes
Our scanner flagged $CLDX 48 times in the last 30 days. Create a free account to track $CLDX, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
Key Stats
- Price
- $40.38
- Change today
- +1.10%
- Previous close
- $39.94
- 52-week range
- $21.34 – $45.14
- Market cap
- $3.14B
- Institutional own.
- 99.9%
- Total held
- 99.9%
- Tradeable float
- 79K 0% of shares · after 100% institutions
- Short interest
- 7.6M ▼ -0% vs prior · as of 2026-07-31
- Days to cover
- 7.6d
- Avg daily volume
- 977K
- Sector
- Health Care
- Industry
- In Vitro & in Vivo Diagnostic Substances
- Exchange
- XNAS
- 5m
- 0.3x
- 15m
- 0.3x
- 1h
- 0.4x
- 1D
- 0.3x
Get free CLDX + market alerts in your inbox
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Why is $CLDX up today?
Here is the latest on CLDX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CLDX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
Likely catalystCelldex Therapeutics, Inc.: Q2 FY2026 results, three months to Jun 30, 2026, from an SEC filing. Read it →Latest filingSC 13G/APassive 5%+ stake updatedAug 14, 2026 · 7 days agoDilution watch
Recent offeringRecent priced share offering — a one-time sale that has already completed (not ongoing). If $CLDX runs, these filings show who may be positioned to sell new or newly-registered shares into the move.
- 10,345,000 new shares · Priced at $29/share
Sourced from SEC EDGAR filings (last 9 months); terms read straight from the filing text where available. Ongoing = an at-the-market (ATM) program still selling over time or a live shelf, so it can keep diluting; Completed = a one-time priced sale that already finished. A shelf (S-3) stays effective ~3 years. Form type signals dilution capacity, not an exact share count, and we can't confirm how much of a shelf or ATM remains unused. Not investment advice.
$CLDX Sentiment
BullishBlend of news sentiment, today’s move, and community votes. Not investment advice.
$CLDX Activity
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Stocks similar to CLDX
Comparable names in in vitro & in vivo diagnostic substances, closest in size first.
CLDX stock FAQ
Why is $CLDX up today?
Here is the latest on CLDX from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for CLDX today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
What is the CLDX stock price today?
CLDX last traded at $40.38, up 1.10% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Where can I see live CLDX alerts?
The CLDX Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged CLDX 48 times in the last 30 days.
What exchange is CLDX on?
CLDX (Celldex Therapeutics, Inc) trades on XNAS, with a market cap of about $3.14B in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector.
Is CLDX good for day trading?
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge CLDX for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.